@article{d8dd30bbbf564f9a97708effc0c67baa,
title = "Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: a retrospective, multicenter study",
abstract = "The aim of this multicenter, retrospective study was to evaluate the efficacy and the safety of single agent Trabectedin (ET-743, Yondelis) in very heavily treated, relapsed ovarian cancer (ROC) patients.",
keywords = "Adult, Aged, Alanine Transaminase, Antineoplastic Agents, Alkylating, Aspartate Aminotransferases, Asthenia, Carcinoma, Dioxoles, Disease-Free Survival, Drug Resistance, Neoplasm, Female, Humans, Middle Aged, Neutropenia, Ovarian Neoplasms, Ovarian cancer, Platinum Compounds, Retrospective Studies, Salvage Therapy, Salvage treatment, Tetrahydroisoquinolines, Trabectedin, Adult, Aged, Alanine Transaminase, Antineoplastic Agents, Alkylating, Aspartate Aminotransferases, Asthenia, Carcinoma, Dioxoles, Disease-Free Survival, Drug Resistance, Neoplasm, Female, Humans, Middle Aged, Neutropenia, Ovarian Neoplasms, Ovarian cancer, Platinum Compounds, Retrospective Studies, Salvage Therapy, Salvage treatment, Tetrahydroisoquinolines, Trabectedin",
author = "Ferrandina, {Maria Gabriella} and Vanda Salutari and Bruno Vincenzi and Marco Marinaccio and Emanuele Naglieri and Vera Loizzi and Silvia Carpano and Giulia Amadio and Giuseppe Tonini and Giovanni Scambia and Domenica Lorusso",
year = "2013",
doi = "10.1016/j.ygyno.2013.06.008",
language = "English",
volume = "130",
pages = "505--510",
journal = "Gynecologic Oncology",
issn = "1095-6859",
publisher = "Academic Press Inc.",
}
